Cargando…
In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla(KPC) or bla(NDM)
BACKGROUND: It is often challenging to select appropriate combination therapies to treat infections caused by carbapenem-resistant Enterobacterales (CRE) with high-level resistance to carbapenem. METHODS: We investigated the in vitro synergistic activity of ceftazidime-avibactam-, polymyxin- or tige...
Autores principales: | Kuai, Junyang, Zhang, Yawei, Lu, Binghuai, Chen, Hongbin, Zhang, Yulin, Li, Henan, Wang, Yuanyuan, Wang, Qi, Wang, Hui, Wang, Xiaojuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224692/ https://www.ncbi.nlm.nih.gov/pubmed/37249967 http://dx.doi.org/10.2147/IDR.S408228 |
Ejemplares similares
-
In vitro Synergistic Activity of Antimicrobial Combinations Against bla(KPC) and bla(NDM)-Producing Enterobacterales With bla(IMP) or mcr Genes
por: Zhou, Chaoe, et al.
Publicado: (2020) -
Rapid Detection of bla
(KPC), bla
(NDM), bla
(OXA-48-like) and bla
(IMP) Carbapenemases in Enterobacterales Using Recombinase Polymerase Amplification Combined With Lateral Flow Strip
por: Wang, Fang, et al.
Publicado: (2021) -
Dynamic evolution of ceftazidime–avibactam resistance due to interchanges between bla(KPC-2) and bla(KPC-145) during treatment of Klebsiella pneumoniae infection
por: Chen, Yili, et al.
Publicado: (2023) -
Neonatal Bloodstream Infection with Ceftazidime-Avibactam-Resistant bla(KPC-2)-Producing Klebsiella pneumoniae Carrying bla(VEB-25)
por: Zarras, Charalampos, et al.
Publicado: (2023) -
Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type 11 Due to a Mutation in Plasmid-Borne bla(kpc-2) to bla(kpc-33), in Henan, China
por: Li, Debao, et al.
Publicado: (2021)